FindTrial
Sign In

A randomized controlled study on the value of contrast-enhanced ultrasound in the early diagnosis of breast cancer in women younger than 40 years old

A randomized controlled study on the value of contrast-enhanced ultrasound in the early diagnosis of breast cancer in women younger than 40 years old

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036689
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-09
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:pathological results
Index test:Operation&#32
rate,&#32
positive&#32
rate&#32
after&#32
operation

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Women under the age of 40 who have breast nodules; and the nodules get pathological results after surgery or puncture.

Exclusion criteria

Exclusion criteria: No complete clinical and imaging data; Contraindications to contrast-enhanced ultrasound.

Design outcomes

Primary

MeasureTime frame
Operation rate;positive rate after operation;SEN, SPE, ACC, AUC of ROC, PPV, NPV;—

Countries

China

Contacts

Public ContactMinghua Yao

Shanghai General Hospital

yaominghua115@163.com+86 136 5164 5860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026